What is United-Guardian's market cap?

United-Guardian (UG) has a market capitalization of $32.4M and trades on NASDAQ.

Who are United-Guardian's competitors?

United-Guardian's key competitors include Ashland Inc., NexGel, Inc Common Stock, Church & Dwight Co., Inc., and others. These companies compete in similar markets and product categories.

Who does United-Guardian partner with?

United-Guardian's notable partners include Brenntag Specialties, ASI.

Where is United-Guardian headquartered?

United-Guardian is headquartered in United States of America and employs approximately 25 people. It has been publicly traded since 1979.

United-Guardian (UG) Stock Fundamentals & Financials

United-Guardian, Inc. is a specialty chemical and pharmaceutical company that develops, manufactures, and markets unique ingredients for the personal care, cosmetic, and healthcare industries.

Market cap

$32.39M-11.2%

Earnings

Q1 2026 report

May 8, 2026

Revenue$2.9M EPS$0.18

Read the full report

Next report

Date not yet announced

Competitors

By market cap

Church & Dwight$23.4B+1.1%

Ashland$3.3B+44.1%

Aurinia Pharmaceuticals$1.9B+38.6%

CorMedix$590.7M-31.8%

Unicycive Therapeutics, Inc.$137.2M+156%

United-Guardian$32.4M-12.0%

SCN

Scienture Holdings, Inc.$15.5M-38.3%

NexGel, Inc.$3.8M-80.5%

By revenue growth

CorMedix+385%

Aurinia Pharmaceuticals+20.6%

Church & Dwight+2.7%

Ashland-1.4%

By net margin

Aurinia Pharmaceuticals99.97%+83.9pp

CorMedix45.25%+58.3pp

Church & Dwight11.96%+3.3pp

Ashland1.09%+47.1pp

Profile

United-Guardian, Inc. is a specialty chemical and pharmaceutical company that develops, manufactures, and markets unique ingredients for the personal care, cosmetic, and healthcare industries. The company leverages its proprietary Guardian Laboratories division to produce high-performance lubricants and medicinal solutions, primarily serving global cosmetic manufacturers and pharmaceutical wholesalers. Its core value proposition centers on specialized research and development that creates high-margin, niche chemical formulations for wellness and medical applications.

Competitive position

The company maintains a niche leadership position through proprietary formulations like Lubrajel and a long-standing FDA-approved pharmaceutical portfolio.

GeographiesUnited States, China, France, Canada, Mexico

Customer segmentsPharmaceutical Wholesalers, Cosmetic Manufacturers, Medical Device Manufacturers, Government Agencies

Business modelManufacturing, B2B, Licensing and Distribution

SuppliersIndustrial organic chemical suppliers, Inorganic chemical suppliers, Pharmaceutical contract manufacturers

CustomersMultinational cosmetic brands, Medical device OEMs, Healthcare providers, Pharmaceutical distributors

CountryUnited States of America

Listed1979

Employees25.0

CEODonna Vigilante

SectorConsumer Defensive

IndustryHousehold & Personal Products

Websiteu-g.com

FilingsSEC EDGAR

FAQ

What is United-Guardian's market cap?: United-Guardian (UG) has a market capitalization of $32.4M and trades on NASDAQ.
Who are United-Guardian's competitors?: United-Guardian's key competitors include Ashland Inc., NexGel, Inc Common Stock, Church & Dwight Co., Inc., and others. These companies compete in similar markets and product categories.
Who does United-Guardian partner with?: United-Guardian's notable partners include Brenntag Specialties, ASI.
Where is United-Guardian headquartered?: United-Guardian is headquartered in United States of America and employs approximately 25 people. It has been publicly traded since 1979.